Back to EIKON THERAPEUTICS, INC.

Eikon Therapeutics, Inc.

All insiders

31 insiders

InsiderRole% of sharesShares heldLast trade
The Column Group IV GP, LP10% owner10.68%5,780,143Feb 6, 2026
Lux Venture Partners V, LLC10% owner4.24%2,294,653Feb 6, 2026
Wolfe JoshDirector · 10% owner4.24%2,294,653Feb 6, 2026
Foresite Capital Management IV, LLC10% owner2.44%1,318,983Feb 4, 2026
PERLMUTTER ROGER MSee remarks · Director0.53%284,857Mar 2, 2026
FRAZIER KENNETH CDirector0.21%111,111Mar 2, 2026
Baynes Roy D.Chief Medical OfficerMar 2, 2026
Bowie Alfred Lloyd Jr.Chief Financial OfficerMar 2, 2026
Chen LeonDirector
Column Group IV-A, LP10% owner
Column Group IV, LP10% owner
Column Group Opportunity III GP, LP10% owner
Column Group Opportunity III, LP10% owner
Foresite Capital Fund IV, L.P.10% owner
Foresite Capital Fund V, L.P.10% owner
Foresite Capital Management V, LLC10% owner
Foresite Capital Opportunity Fund V, L.P.10% owner
Foresite Capital Opportunity Management V, LLC10% owner
Foresite Capital VI-A, LLC10% owner
Foresite Capital VI-A Management, LLC10% owner
Hebert Peter10% owner
Huffines Robert LutherDirectorMar 2, 2026
Klobuchar Michael AChief Operating OfficerMar 2, 2026
Kutzkey Tim10% owner
Lux Co-Invest Opportunities II, L.P.10% owner
Lux Total Opportunities, L.P.10% owner
Lux Ventures V, L.P.10% owner
Meline David WDirector
Svennilson Peter10% owner
TCG Opportunity III GP, LLC10% owner
Thorner Benjamin BrunoSee RemarksMar 2, 2026
← PrevPage 1 of 1Next →